CQUniversity
Browse
A putative fifth serotype of Dengue CQU.pdf (351.41 kB)

A putative fifth serotype of dengue - Potential implications for diagnosis, therapy and vaccine design

Download (351.41 kB)
Version 2 2022-08-16, 23:08
Version 1 2018-09-04, 00:00
journal contribution
posted on 2022-08-16, 23:08 authored by Andrew Taylor-Robinson
Dengue is now established as the world’s most important arboviral infection. This Aedes mosquitotransmitted pathogen is considered to be the cause of a major re-emerging tropical disease and significant public health concern. Four distinct but genetically similar serotypes of dengue virus, DENV 1-4, are responsible for provoking a spectrum of clinical symptoms in humans that range from mild fever to severe haemorrhagic manifestations. Recently, a phylogenetically more distant fifth serotype has been mooted. Confirmation of the identification of this virus is required before its status as DENV-5 can be formally recognized. Nevertheless, the possibility of a further serotype raises the spectre of those antidengue therapies and vaccines predicated on DENV 1-4 that are currently under clinical trial being intrinsically suboptimal. Hence, the potential impact of the existence of DENV-5 and other sylvatic arboviruses on the strategy to combat dengue fever and related pyrexias of unknown origin should be considered in order to refine guidelines for diagnosis, treatment, prevention and control.

History

Volume

1

Issue

1

Start Page

1

End Page

2

Number of Pages

2

eISSN

2456-4028

Publisher

Graphy Publications

Additional Rights

Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Peer Reviewed

  • Yes

Open Access

  • Yes

Acceptance Date

2016-02-28

Era Eligible

  • Yes

Journal

International Journal of Clinical & Medical Microbiology

Usage metrics

    CQUniversity

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC